We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.15%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,185

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXS
2751
DELISTED
Invesco CurrencyShares Swedish Krona Trust
FXS
$10K ﹤0.01%
83
-17
-17% -$2K
OSIR
2752
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$10K ﹤0.01%
526
-463
-47% -$8.19K
EIO
2753
DELISTED
Eaton Vance Ohio Municipal Bond Fund
EIO
$10K ﹤0.01%
+801
New +$10.2K
SBSA
2754
DELISTED
Spanish Broadcasting System Inc.
SBSA
$10K ﹤0.01%
1,525
+710
+87% +$4.26K
WRES
2755
DELISTED
WARREN RESOURCES INC
WRES
$10K ﹤0.01%
21,410
+18,518
+640% +$15.9K
DDC
2756
DELISTED
Dominion Diamond Corporation
DDC
$10K ﹤0.01%
571
-140
-20% -$2.54K
ACU icon
2757
Acme United Corp
ACU
$213M
$9K ﹤0.01%
502
+302
+151% +$5.51K
AMKR icon
2758
Amkor Technology
AMKR
$13.7B
$9K ﹤0.01%
1,515
-6,752
-82% -$48.7K
ARES icon
2759
Ares Management
ARES
$30.9B
$9K ﹤0.01%
+500
New +$9.44K
ATI icon
2760
ATI
ATI
$31.1B
$9K ﹤0.01%
300
-575
-66% -$19K
AVDL
2761
DELISTED
Avadel Pharmaceuticals
AVDL
$9K ﹤0.01%
+441
New +$7.91K
AXGN icon
2762
Axogen
AXGN
$2.5B
$9K ﹤0.01%
3,003
+2,810
+1,456% +$9.07K
BBW icon
2763
Build-A-Bear
BBW
$462M
$9K ﹤0.01%
565
-86
-13% -$1.52K
BFH icon
2764
Bread Financial
BFH
$4.38B
$9K ﹤0.01%
40
-336
-89% -$80.4K
BRID icon
2765
Bridgford Foods
BRID
$56.5M
$9K ﹤0.01%
952
+387
+68% +$3.33K
SLAI
2766
DELISTED
SOLAI Ltd ADS
SLAI
$9K ﹤0.01%
5
-62
-93% -$90.4K
BUI icon
2767
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$715M
$9K ﹤0.01%
+514
New +$9.95K
CBAN icon
2768
Colony Bankcorp
CBAN
$467M
$9K ﹤0.01%
1,098
+560
+104% +$4.72K
CEF icon
2769
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$9K ﹤0.01%
600
-900
-60% -$10.8K
MBAI
2770
Check-Cap
MBAI
$10.9M
$9K ﹤0.01%
11
+7
+175% +$7.31K
COLL icon
2771
Collegium Pharmaceutical
COLL
$956M
$9K ﹤0.01%
+506
New +$8.75K
CTRE icon
2772
CareTrust REIT
CTRE
$9.74B
$9K ﹤0.01%
709
-520
-42% -$6.8K
DKS icon
2773
Dick's Sporting Goods
DKS
$18.7B
$9K ﹤0.01%
+175
New +$9.62K
DSGR icon
2774
Distribution Solutions Group
DSGR
$1.61B
$9K ﹤0.01%
800
-1,124
-58% -$13.1K
EQNR icon
2775
Equinor
EQNR
$92.4B
$9K ﹤0.01%
+500
New +$9.67K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,185 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.